Evidence review · Published July 22, 2026 · Sources checked July 22, 2026

Selank research overview

Selank is a synthetic heptapeptide analogue derived from the immunomodulatory peptide tuftsin.

Evidence boundary: published research does not establish the identity or performance of a separately supplied batch. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.

What is Selank?

Selected studies have used rat chronic-stress, behavioral, cytokine, and withdrawal models, sometimes comparing or combining Selank with other compounds.

Research category

Neuro research

Study models represented

Rat stress, behavioral, cytokine, and withdrawal models

Names in the literature

Thr-Lys-Pro-Arg-Pro-Gly-Pro; tuftsin analogue

Primary boundary

Rodent behavioral outcomes do not demonstrate human safety or efficacy.

What does the selected evidence support?

Animal behavioral and gene-expression observations are hypothesis-generating and do not establish anxiolytic or other clinical effects in humans.

Primary sources

1. Kasian et al., BioMed Research International (2017) — Rat chronic-stress experiments examining Selank and diazepam interactions. DOI: 10.1155/2017/5091027
2. Konstantinopolsky et al., Bulletin of Experimental Biology and Medicine (2022) — Rat morphine-withdrawal behavioral model. DOI: 10.1007/s10517-022-05624-x

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Review Selank product specifications · Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.